Compare ARK Genomic Revolution ETF (ARKG) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Nano Dimension Ltd - ADR — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Nano Dimension Ltd - ADR trades at $1.48 (market cap $314.71M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | NNDM | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $2.14 |
52-Week Low | $23.09 | $1.21 |
Market Cap | — | $314.71M |
Enterprise Value | — | -$94.63M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Nano Dimension (NNDM) trades at $1.50, showing no daily change. The technical signal is mixed with a bullish overall signal but bearish moving averages. Fundamentally, the company reported revenue growth to $102.44M in 2025, but net losses deepened to -$293.30M, with a negative net income margin of -286.72%. Recent news highlights boardroom disputes with shareholder Murchinson and a proposed business combination with Infinite Epigenetics.
The outlook remains challenging due to persistent losses and negative cash flow, though the low P/B ratio of 0.65 may attract value investors. Key risks include execution of strategic plans, shareholder activism, and achieving profitability. Analyst sentiment is cautious given the financial performance and corporate governance concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
